Trials / Conditions / Stage II Renal Cell Cancer

Stage II Renal Cell Cancer

13 registered clinical trials studyying Stage II Renal Cell Cancer — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial NCT06432036	Jonsson Comprehensive Cancer Center	Phase 1 / Phase 2
Recruiting	An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent NCT06447103	Jonsson Comprehensive Cancer Center	Phase 2
Recruiting	Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer NCT04473781	Jonsson Comprehensive Cancer Center	Phase 1
Terminated	sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer NCT02767921	University of Southern California	Phase 1
Active Not Recruiting	Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer NCT02664883	University of Southern California	—
Unknown	Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors NCT02526511	Rutgers, The State University of New Jersey	N/A
Terminated	Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer NCT02170389	Roswell Park Cancer Institute	N/A
Completed	Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520	City of Hope Medical Center	N/A
Withdrawn	Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer NCT01769885	Roswell Park Cancer Institute	N/A
Completed	Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors NCT01281488	City of Hope Medical Center	Phase 1
Completed	Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies NCT01243359	National Cancer Institute (NCI)	Phase 1
Completed	Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer NCT01158521	Case Comprehensive Cancer Center	Phase 2
Completed	Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors NCT00335556	Children's Oncology Group	Phase 2